Search by Drug Name or NDC

    NDC 00054-0319-50 Linezolid 100 mg/5mL Details

    Linezolid 100 mg/5mL

    Linezolid is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is LINEZOLID.

    Product Information

    NDC 00054-0319
    Product ID 0054-0319_54d662b1-db69-44cd-9bbf-b2d018aa43f6
    Associated GPIs 16230040001920
    GCN Sequence Number 045132
    GCN Sequence Number Description linezolid SUSP RECON 100 MG/5ML ORAL
    HIC3 W1O
    HIC3 Description OXAZOLIDINONE ANTIBIOTICS
    GCN 26871
    HICL Sequence Number 021157
    HICL Sequence Number Description LINEZOLID
    Brand/Generic Generic
    Proprietary Name Linezolid
    Proprietary Name Suffix n/a
    Non-Proprietary Name linezolid
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/5mL
    Substance Name LINEZOLID
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200068
    Listing Certified Through 2024-12-31

    Package

    NDC 00054-0319-50 (00054031950)

    NDC Package Code 0054-0319-50
    Billing NDC 00054031950
    Package 150 mL in 1 BOTTLE (0054-0319-50)
    Marketing Start Date 2015-06-03
    NDC Exclude Flag N
    Pricing Information N/A